Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. The Supreme Court is allowing the Trump administration to cut $783 million in research grants tied to DEI work. Also, STAT just unveiled its special report on the 2025 rankings of the top venture capital firms in biotech.
FDA clears Ionis’ therapy for rare swelling disorder
Ionis Pharmaceuticals yesterday won Food and Drug Administration approval for Dawnzera, its antisense drug for patients with hereditary angioedema, a rare and dangerous disorder.
Continue to STAT+ to read the full story…
